ID   DAXX_RAT                Reviewed;         731 AA.
AC   Q8VIB2;
DT   01-NOV-2002, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2002, sequence version 1.
DT   02-OCT-2024, entry version 140.
DE   RecName: Full=Death domain-associated protein 6;
DE   AltName: Full=Daxx;
GN   Name=Daxx;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RA   Mizuta H., Usui T., Nakamura Y., Murabe H., Nakao K.;
RT   "Cloning and characterization of rat Daxx that enhances the transcription
RT   activity of hERalpha.";
RL   Submitted (JUL-2001) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-488; SER-490; SER-527;
RP   SER-551 AND SER-571, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: Transcription corepressor known to repress transcriptional
CC       potential of several sumoylated transcription factors. Down-regulates
CC       basal and activated transcription. Its transcription repressor activity
CC       is modulated by recruiting it to subnuclear compartments like the
CC       nucleolus or PML/POD/ND10 nuclear bodies through interactions with
CC       MCSR1 and PML, respectively. Seems to regulate transcription in
CC       PML/POD/ND10 nuclear bodies together with PML and may influence
CC       TNFRSF6-dependent apoptosis thereby. Inhibits transcriptional
CC       activation of PAX3 and ETS1 through direct protein-protein
CC       interactions. Modulates PAX5 activity; the function seems to involve
CC       CREBBP. Acts as an adapter protein in a MDM2-DAXX-USP7 complex by
CC       regulating the RING-finger E3 ligase MDM2 ubiquitination activity.
CC       Under non-stress condition, in association with the deubiquitinating
CC       USP7, prevents MDM2 self-ubiquitination and enhances the intrinsic E3
CC       ligase activity of MDM2 towards TP53, thereby promoting TP53
CC       ubiquitination and subsequent proteasomal degradation. Upon DNA damage,
CC       its association with MDM2 and USP7 is disrupted, resulting in increased
CC       MDM2 autoubiquitination and consequently, MDM2 degradation, which leads
CC       to TP53 stabilization. Acts as a histone chaperone that facilitates
CC       deposition of histone H3.3. Acts as a targeting component of the
CC       chromatin remodeling complex ATRX:DAXX which has ATP-dependent DNA
CC       translocase activity and catalyzes the replication-independent
CC       deposition of histone H3.3 in pericentric DNA repeats outside S-phase
CC       and telomeres, and the in vitro remodeling of H3.3-containing
CC       nucleosomes. Does not affect the ATPase activity of ATRX but alleviates
CC       its transcription repression activity. Upon neuronal activation
CC       associates with regulatory elements of selected immediate early genes
CC       where it promotes deposition of histone H3.3 which may be linked to
CC       transcriptional induction of these genes. Required for the recruitment
CC       of histone H3.3:H4 dimers to PML-nuclear bodies (PML-NBs); the process
CC       is independent of ATRX and facilitated by ASF1A; PML-NBs are suggested
CC       to function as regulatory sites for the incorporation of newly
CC       synthesized histone H3.3 into chromatin. Proposed to mediate activation
CC       of the JNK pathway and apoptosis via MAP3K5 in response to signaling
CC       from TNFRSF6 and TGFBR2. Interaction with HSPB1/HSP27 may prevent
CC       interaction with TNFRSF6 and MAP3K5 and block DAXX-mediated apoptosis.
CC       In contrast, in lymphoid cells JNC activation and TNFRSF6-mediated
CC       apoptosis may not involve DAXX. Plays a role as a positive regulator of
CC       the heat shock transcription factor HSF1 activity during the stress
CC       protein response (By similarity). {ECO:0000250,
CC       ECO:0000250|UniProtKB:Q9UER7}.
CC   -!- SUBUNIT: Homomultimer. Interacts (via C-terminus) with TNFRSF6 (via
CC       death domain). Interacts with PAX5, SLC2A4/GLUT4, MAP3K5, TGFBR2,
CC       phosphorylated dimeric HSPB1/HSP27, CENPC, ETS1, sumoylated PML, UBE2I,
CC       MCRS1 and TP53. Interacts (via N-terminus) with HIPK2 and HIPK3.
CC       Interacts with HIPK1, which induces translocation from PML/POD/ND10
CC       nuclear bodies to chromatin and enhances association with HDAC1.
CC       Interacts (non-phosphorylated) with PAX3, PAX7, DEK, HDAC1, HDAC2,
CC       HDAC3, acetylated histone H4 and histones H2A, H2B, H3, H3.3 and H4.
CC       Interacts with SPOP; mediating CUL3-dependent proteasomal degradation.
CC       Interacts with CBP; the interaction is dependent the sumoylation of CBP
CC       and suppresses CBP transcriptional activity via recruitment of HDAC2
CC       directly in the complex with TP53 and HIPK2. Interacts with AXIN1; the
CC       interaction stimulates the interaction of DAXX with TP53, stimulates
CC       'Ser-46' phosphorylation of TP53 on and induces cell death on UV
CC       irradiation. Interacts with MDM2; the interaction is direct. Interacts
CC       with USP7; the interaction is direct and independent of MDM2 and TP53.
CC       Part of a complex with DAXX, MDM2 and USP7 under non-stress conditions.
CC       Interacts (via N-terminus) with RASSF1 (via C-terminus); the
CC       interaction is independent of MDM2 and TP53; RASSF1 isoform A disrupts
CC       interactions among MDM2, DAXX and USP7, thus contributing to the
CC       efficient activation of TP53 by promoting MDM2 self-ubiquitination in
CC       cell-cycle checkpoint control in response to DNA damage. Interacts with
CC       ATRX to form the chromatin remodeling complex ATRX:DAXX (By
CC       similarity). Interacts with HSF1 (via homotrimeric form
CC       preferentially); this interaction relieves homotrimeric HSF1 from
CC       repression of its transcriptional activity by HSP90-dependent
CC       multichaperone complex upon heat shock (By similarity). {ECO:0000250,
CC       ECO:0000250|UniProtKB:Q9UER7}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:Q9UER7}.
CC       Nucleus, nucleoplasm {ECO:0000250|UniProtKB:Q9UER7}. Nucleus, PML body
CC       {ECO:0000250|UniProtKB:Q9UER7}. Nucleus, nucleolus
CC       {ECO:0000250|UniProtKB:Q9UER7}. Chromosome, centromere
CC       {ECO:0000250|UniProtKB:Q9UER7}. Note=Dispersed throughout the
CC       nucleoplasm, in PML/POD/ND10 nuclear bodies, and in nucleoli.
CC       Colocalizes with histone H3.3, ATRX, HIRA and ASF1A at PML-nuclear
CC       bodies. Colocalizes with a subset of interphase centromeres, but is
CC       absent from mitotic centromeres. Detected in cytoplasmic punctate
CC       structures. Translocates from the nucleus to the cytoplasm upon glucose
CC       deprivation or oxidative stress. Colocalizes with RASSF1 in the
CC       nucleus. Colocalizes with USP7 in nucleoplasma with accumulation in
CC       speckled structures. {ECO:0000250|UniProtKB:Q9UER7}.
CC   -!- DOMAIN: The Sumo interaction motif mediates Sumo binding, and is
CC       required both for sumoylation and binding to sumoylated targets.
CC       {ECO:0000250}.
CC   -!- PTM: Sumoylated with SUMO1 on multiple lysine residues. {ECO:0000250}.
CC   -!- PTM: Repressor activity is down-regulated upon Ser-661 phosphorylation.
CC       Upon neuronal activation dephosphorylated by calcineurin in a Ca2+
CC       dependent manner at Ser-661; dephosphorylation positively affects
CC       histone H3.3 loading and transcriptional activation (By similarity).
CC       {ECO:0000250}.
CC   -!- PTM: Polyubiquitinated; which is promoted by CUL3 and SPOP and results
CC       in proteasomal degradation. Ubiquitinated by MDM2; inducing its
CC       degradation. Deubiquitinated by USP7; leading to stabilize it (By
CC       similarity). {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the DAXX family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB064671; BAB83524.1; -; mRNA.
DR   AlphaFoldDB; Q8VIB2; -.
DR   BMRB; Q8VIB2; -.
DR   SMR; Q8VIB2; -.
DR   IntAct; Q8VIB2; 4.
DR   MINT; Q8VIB2; -.
DR   STRING; 10116.ENSRNOP00000000559; -.
DR   iPTMnet; Q8VIB2; -.
DR   PhosphoSitePlus; Q8VIB2; -.
DR   PaxDb; 10116-ENSRNOP00000000559; -.
DR   UCSC; RGD:621227; rat.
DR   AGR; RGD:621227; -.
DR   RGD; 621227; Daxx.
DR   eggNOG; ENOG502QRS6; Eukaryota.
DR   InParanoid; Q8VIB2; -.
DR   PhylomeDB; Q8VIB2; -.
DR   Reactome; R-RNO-3899300; SUMOylation of transcription cofactors.
DR   Reactome; R-RNO-6804757; Regulation of TP53 Degradation.
DR   PRO; PR:Q8VIB2; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0044297; C:cell body; IDA:RGD.
DR   GO; GO:0005938; C:cell cortex; IDA:RGD.
DR   GO; GO:0000775; C:chromosome, centromeric region; ISO:RGD.
DR   GO; GO:0005829; C:cytosol; ISS:UniProtKB.
DR   GO; GO:0000792; C:heterochromatin; ISO:RGD.
DR   GO; GO:0005874; C:microtubule; IDA:RGD.
DR   GO; GO:0005730; C:nucleolus; IEA:UniProtKB-SubCell.
DR   GO; GO:0005634; C:nucleus; ISS:UniProtKB.
DR   GO; GO:0016605; C:PML body; IDA:RGD.
DR   GO; GO:0001741; C:XY body; IDA:RGD.
DR   GO; GO:0019899; F:enzyme binding; ISO:RGD.
DR   GO; GO:0042393; F:histone binding; ISO:RGD.
DR   GO; GO:0008432; F:JUN kinase binding; IPI:RGD.
DR   GO; GO:0019894; F:kinesin binding; IPI:RGD.
DR   GO; GO:0140693; F:molecular condensate scaffold activity; ISO:RGD.
DR   GO; GO:0050681; F:nuclear androgen receptor binding; IPI:RGD.
DR   GO; GO:0002039; F:p53 binding; ISO:RGD.
DR   GO; GO:0042803; F:protein homodimerization activity; ISS:UniProtKB.
DR   GO; GO:0030295; F:protein kinase activator activity; ISO:RGD.
DR   GO; GO:0019901; F:protein kinase binding; IPI:RGD.
DR   GO; GO:0061629; F:RNA polymerase II-specific DNA-binding transcription factor binding; ISS:UniProtKB.
DR   GO; GO:0003713; F:transcription coactivator activity; ISS:UniProtKB.
DR   GO; GO:0003714; F:transcription corepressor activity; ISO:RGD.
DR   GO; GO:0140416; F:transcription regulator inhibitor activity; ISO:RGD.
DR   GO; GO:0031625; F:ubiquitin protein ligase binding; ISO:RGD.
DR   GO; GO:0030521; P:androgen receptor signaling pathway; ISO:RGD.
DR   GO; GO:0097190; P:apoptotic signaling pathway; ISO:RGD.
DR   GO; GO:0008283; P:cell population proliferation; ISO:RGD.
DR   GO; GO:0071276; P:cellular response to cadmium ion; ISS:UniProtKB.
DR   GO; GO:0071280; P:cellular response to copper ion; ISS:UniProtKB.
DR   GO; GO:0072738; P:cellular response to diamide; ISS:UniProtKB.
DR   GO; GO:0034605; P:cellular response to heat; ISS:UniProtKB.
DR   GO; GO:0070301; P:cellular response to hydrogen peroxide; IEP:RGD.
DR   GO; GO:1903936; P:cellular response to sodium arsenite; ISS:UniProtKB.
DR   GO; GO:0071356; P:cellular response to tumor necrosis factor; IEP:RGD.
DR   GO; GO:0071346; P:cellular response to type II interferon; IMP:RGD.
DR   GO; GO:0034620; P:cellular response to unfolded protein; ISS:UniProtKB.
DR   GO; GO:0006338; P:chromatin remodeling; ISO:RGD.
DR   GO; GO:0008625; P:extrinsic apoptotic signaling pathway via death domain receptors; ISO:RGD.
DR   GO; GO:0007254; P:JNK cascade; ISO:RGD.
DR   GO; GO:0000281; P:mitotic cytokinesis; ISO:RGD.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; ISO:RGD.
DR   GO; GO:1900038; P:negative regulation of cellular response to hypoxia; IMP:RGD.
DR   GO; GO:0045892; P:negative regulation of DNA-templated transcription; ISO:RGD.
DR   GO; GO:0010629; P:negative regulation of gene expression; ISS:UniProtKB.
DR   GO; GO:0010832; P:negative regulation of myotube differentiation; IDA:RGD.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; IDA:RGD.
DR   GO; GO:0036480; P:neuron intrinsic apoptotic signaling pathway in response to oxidative stress; ISO:RGD.
DR   GO; GO:0006334; P:nucleosome assembly; ISO:RGD.
DR   GO; GO:0030578; P:PML body organization; IMP:RGD.
DR   GO; GO:0043065; P:positive regulation of apoptotic process; IMP:RGD.
DR   GO; GO:2001235; P:positive regulation of apoptotic signaling pathway; ISO:RGD.
DR   GO; GO:0001934; P:positive regulation of protein phosphorylation; ISO:RGD.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; ISO:RGD.
DR   GO; GO:0071168; P:protein localization to chromatin; ISO:RGD.
DR   GO; GO:0042981; P:regulation of apoptotic process; IBA:GO_Central.
DR   GO; GO:0006355; P:regulation of DNA-templated transcription; ISO:RGD.
DR   GO; GO:0010468; P:regulation of gene expression; ISO:RGD.
DR   GO; GO:0040014; P:regulation of multicellular organism growth; ISO:RGD.
DR   GO; GO:0031396; P:regulation of protein ubiquitination; ISS:UniProtKB.
DR   GO; GO:0010038; P:response to metal ion; IEP:RGD.
DR   CDD; cd13151; DAXX_helical_bundle; 1.
DR   CDD; cd13150; DAXX_histone_binding; 1.
DR   Gene3D; 1.20.58.2170; -; 1.
DR   Gene3D; 1.10.8.810; Daxx helical bundle domain; 1.
DR   InterPro; IPR046378; DAXX_histone-bd.
DR   InterPro; IPR046426; DAXX_histone-bd_sf.
DR   InterPro; IPR031333; Daxx_N.
DR   InterPro; IPR038298; Daxx_N_sf.
DR   PANTHER; PTHR12766:SF9; DEATH DOMAIN-ASSOCIATED PROTEIN 6; 1.
DR   PANTHER; PTHR12766; DEATH DOMAIN-ASSOCIATED PROTEIN 6 DAXX; 1.
DR   Pfam; PF03344; Daxx; 1.
DR   Pfam; PF20920; DAXX_hist_bd; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Apoptosis; Centromere; Chaperone; Chromatin regulator;
KW   Chromosome; Coiled coil; Cytoplasm; Isopeptide bond; Nucleus;
KW   Phosphoprotein; Reference proteome; Repressor; Transcription;
KW   Transcription regulation; Ubl conjugation.
FT   CHAIN           1..731
FT                   /note="Death domain-associated protein 6"
FT                   /id="PRO_0000151260"
FT   REGION          1..158
FT                   /note="Necessary for interaction with USP7 and ATRX"
FT                   /evidence="ECO:0000250"
FT   REGION          1..56
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          147..183
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          181..414
FT                   /note="Interaction with histone H3.3"
FT                   /evidence="ECO:0000250"
FT   REGION          345..560
FT                   /note="Necessary for interaction with USP7"
FT                   /evidence="ECO:0000250"
FT   REGION          381..639
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          617..731
FT                   /note="Interaction with SPOP"
FT                   /evidence="ECO:0000250"
FT   REGION          663..688
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          724..731
FT                   /note="Sumo interaction motif (SIM)"
FT                   /evidence="ECO:0000250"
FT   COILED          177..215
FT                   /evidence="ECO:0000255"
FT   COILED          368..395
FT                   /evidence="ECO:0000255"
FT   COILED          428..485
FT                   /evidence="ECO:0000255"
FT   MOTIF           391..395
FT                   /note="Nuclear localization signal"
FT                   /evidence="ECO:0000255"
FT   MOTIF           622..628
FT                   /note="Nuclear localization signal"
FT                   /evidence="ECO:0000255"
FT   COMPBIAS        150..180
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        381..395
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        396..426
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        429..482
FT                   /note="Acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        501..518
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        582..610
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         25
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UER7"
FT   MOD_RES         211
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UER7"
FT   MOD_RES         409
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UER7"
FT   MOD_RES         421
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UER7"
FT   MOD_RES         456
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:O35613"
FT   MOD_RES         485
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UER7"
FT   MOD_RES         488
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         490
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         499
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O35613"
FT   MOD_RES         503
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UER7"
FT   MOD_RES         527
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         551
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         571
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         617
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O35613"
FT   MOD_RES         661
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O35613"
FT   MOD_RES         662
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UER7"
FT   MOD_RES         679
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UER7"
FT   MOD_RES         693
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UER7"
FT   MOD_RES         728
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UER7"
FT   MOD_RES         730
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UER7"
FT   CROSSLNK        142
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UER7"
FT   CROSSLNK        621
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO1)"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UER7"
SQ   SEQUENCE   731 AA;  80687 MW;  17EEBAAB5AA73157 CRC64;
     MATDDSIIVL DDDDEDEAAA QPGPSNPASN PVSPGPEASG PSESHGDGGS SNSGSRKCYK
     LENEKLFEEF LELCKMQTSD HPEVVPFLHK LQQRAQSAFL ASAEFRNILS RVLSRSRNRP
     AKLYVYINEL CTVLKAHSIK KKLNLAPAAS AESSGDNPPT DPPSDLTNTE TTASEASRTR
     GSRRQIQRLE QLLALYVAEI QRLQEKELDL SELDDPDSSY LQEARLKRKL IRLFGRLCDL
     KDCSSLTGKV IEQRIPYRGT RYPEVNRRIE RLINKPGPDT FPDYGDVLRA VEKAATRHSL
     GLPRQQLQLL AQDAFRDVGV RLQERRHLDL IYNFGCHLTD DYRPGVDPAL TDPTLARRLR
     ENRTLAMSRL DEVISKYAMM QDKSEEGERQ KRRARLLATS QSSDLPKASS DSGEGPSGVA
     SQEDPTTPKA ETEDEEDDEE SDDEEEEEEE EEEEATEDED EDLEQLQEDQ DDEEEEEGDN
     EDDKSPASPS PIFRRKEFSN PQKGSGPQEE QQERGLTGTP ASPLEASPGL PSTDAESSGE
     QLQERLLAGE SPVSQLSELD MEALPEETIP SPEERGISSS RRKSDSSLPT ILENGAAMVT
     STSFNGRVSS HPCRDASPPS KRFRKEKKQL GPGPLGNSYV KKQTMAQQDS GWKISVLSTP
     SSPLASVGPV ADSSTRVDSP SHELVTSSLC NPSPSLILQT PQSQSPRPCI YKTSVATQCD
     PEEIIVLSDS D
//
